Found: 6
Select item for more details and to access through your institution.
Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 1, p. 33, doi. 10.1177/1078155220908948
- By:
- Publication type:
- Article
Outcomes of therapy‐related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 24, doi. 10.1111/ejh.13403
- By:
- Publication type:
- Article
Reduced‐intensity conditioning allogeneic transplant with dual T‐cell depletion in myelofibrosis.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 6, p. 597, doi. 10.1111/ejh.13327
- By:
- Publication type:
- Article
Reduced intensity allogeneic stem cell transplant with anti‐thymocyte globulin and post‐transplant cyclophosphamide in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 5, p. 510, doi. 10.1111/ejh.13321
- By:
- Publication type:
- Article
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 6, p. 486, doi. 10.1111/ejh.13230
- By:
- Publication type:
- Article
Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 4, p. 273, doi. 10.1111/ejh.12338
- By:
- Publication type:
- Article